newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference

HAYWARD, Calif., Sept. 6, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, t